CNBC’s Jim Cramer on Tuesday expressed some disappointment in Tesla‘s first-quarter earnings report and subsequent conference call. “I have to be somewhat critical. This was not the blowout quarter,” Cramer said on “Squawk on the Street,” describing the numbers released Monday by the electric vehicle maker as “very good” relative to certain industry peers. He
admin
In this article UBSG-CH CROX TSLA Victor J. Blue | Bloomberg | Getty Images Check out the companies making headlines in midday trading. Tesla — Shares of the electric vehicle company slipped nearly 2%, despite headline beats on earnings and revenue for Tesla’s first quarter. The company’s net profit was boosted by regulatory credits and
California-based EV start-up Fisker (NYSE:FSR) stock has shed more than 27% of its value in the past month. Momentum stocks such as Fisker took a hit in March and are now trading at a more attractive price point. Source: Eric Broder Van Dyke / Shutterstock.com The price drop comes when CEO Henrik Fisker recently announced 13,000
Capitalism, at least in its pure theoretical form, is supposed to reward success and punish failure. Build a better mousetrap, sell enough units at a sufficiently high markup, and you’ll prosper. Burn through billions of dollars of investors’ money without showing a profit, and you should cease operations and find yourself another line of work.
Find Stocks Likely to Surprise with 70% Accuracy Earnings ESP has proven to be a very valuable tool for investors seeking stocks that are most likely to beat earnings estimates. As indicated earlier, in our extensive 10- year backtest, we found that over the past decade, stocks with a positive Earnings ESP and with a
Since February, Wall Street can’t see the forest for the trees when it comes to renewable energy stocks. Investors are focused on minor issues while seemingly forgetting that the fundamentals for these equities remain incredibly strong. Over the past ten or so weeks, solar energy stocks have been especially weak. Since the end of January,
As a shareholder of Aurora Cannabis (NYSE:ACB), I’m going to get this one out of the way. This was not one of my brightest ideas. In my mind, I’ve already resigned to the very real possibility that ACB stock will be a tax write-off for me. Still, if there’s any hope for the cannabis firm,
Jeff Bezos and Elon Musk Getty Images Jeff Bezos‘ Blue Origin filed a protest with the Government Accountability Office against NASA on Monday, challenging the space agency’s award of a nearly $3 billion moon lander contract to Elon Musk’s SpaceX earlier this month. SpaceX, in a competition against Blue Origin and Leidos‘ subsidiary Dynetics, was
In this article LYFT NXPI TSLA SNAP A man walks in front of a GameStop store in the Jackson Heights neighborhood of New York City, New York, Jan. 27, 2021. Nick Zieminski | Reuters Check out the companies making headlines after the bell on Monday: Tesla — Shares of the electric vehicle maker slipped 1%
The healthcare sector is an excellent place to find high-quality companies that produce consistent growth over long periods of time. Because of the continuously strong demand for healthcare, there are many blue-chip healthcare stocks that pay dividends to shareholders that grow over time. Healthcare stocks should see growth moving forward, due to a major demographic
The mania surrounding FuboTV (NYSE:FUBO) has long since faded. Trading for as much as $62.29 per share in late 2020, sports streaming and wagering play FUBO stock made a partial rebound during February’s wildness surrounding “meme stocks.” Source: monticello / Shutterstock.com But, since that brief trend fizzled out, this stock has basically collapsed. Now changing
Nio (NYSE:NIO) will release its first quarter sales and earnings on Thursday, April 29, after having pre-released on April 1 the delivery numbers for the quarter. As a result, Nio stock could move higher, especially if the company updates its outlook for the rest of the year. My assessment is that Nio is worth $73.34,
OK, let’s wrap our heads around this one: Ocugen (NASDAQ:OCGN) has a $1.4 billion market capitalization. But its entire pipeline is still in preclinical trials for various ophthalmic conditions. And it’s been around for just over five years. What is going on with OCGN stock? Source: Shutterstock A similar company in the space, EyePoint Pharmaceuticals
Employees bring a television to Steve Steward’s car at a Best Buy store on Black Friday, traditionally one of the busiest shopping days of the year. Crowds are smaller this year due to the increasing popularity of on-line shopping amid concerns about the COVID-19 pandemic. Paul Hennessy | SOPA Images | LightRocket | Getty Images
Aphria (NASDAQ:APHA) stock could be in trouble. The company reported terrible fiscal third-quarter results on April 12, indicating that my negative thesis on marijuana stocks remains very much intact. Source: Shutterstock Moreover, the outlook of Aphria’s merger partner, Tilray (NASDAQ:TLRY), is worsening. Given these points, I recommend that investors sell APHA stock. There are new indications
Stitch Fix reported some disappointing numbers for the quarter and the stock is under pressure.
More than 24.9 million households in the U.S. have Roth individual retirement accounts, which accounted for $1.02 trillion in retirement assets as of 2019, according to the Investment Company Institute. The retirement savings vehicles are funded with after-tax dollars, which means distributions are tax-free. Key Takeaways Roth IRAs are retirement savings vehicles that are funded
Plug Power (NASDAQ:PLUG) stock is completely mispriced. In fact, many hydrogen stocks are ridiculously oversold at this point. Source: Shutterstock At the moment, PLUG stock trades just under its 200-day moving average. It’s also oversold on relative strength (RSI), MACD, and Williams’ %R, which I’d use as an opportunity to buy. With patience, (and greener days
This is my first time writing about C3.AI Inc (NYSE:AI) stock. It seems the big question on investors’ minds is if, or when, to buy AI stock. Source: shutterstock Since soaring well above its IPO price, the stock is trending toward $70 this morning. I found this article by Ian Bezek extremely helpful in understanding
Retail investors can’t seem to get enough of Microvision (NASDAQ:MVIS). MVIS stock, which is up almost 30% in two days, is one of the hottest conversation topics on r/WallStreetBets and other social communities. Anointed as the next “battleground” play, MVIS is a target largely because of the stock’s whopping 18% short interest. With an upcoming